Cooper Tire & Rubber Company (NYSE:CTB) Logo Cooper Tire & Rubber Co (CTB) investors sentiment increased to 1.12 in Q3 2018 . It’s up 0.22, from 0.9 in 2018Q2. The ratio improved, as 82 investment managers opened new or increased stock positions, while 73 decreased and sold their stock positions in Cooper Tire & Rubber Co. The investment managers in our database now have: 53.97 million shares, up from 52.62 million shares in 2018Q2. Also, the number of investment managers holding Cooper Tire & Rubber Co in top ten stock positions was flat from 2 to 2 for the same number . Sold All: 25 Reduced: 48 Increased: 58 New Position: 24.
Analysts expect Assertio Therapeutics, Inc. (NASDAQ:ASRT) to report $-0.30 EPS on February, 26.They anticipate $0.08 EPS change or 21.05% from last quarter’s $-0.38 EPS. After having $0.65 EPS previously, Assertio Therapeutics, Inc.’s analysts see -146.15% EPS growth. The stock decreased 4.51% or $0.2022 during the last trading session, reaching $4.2778. About 358,981 shares traded. Assertio Therapeutics, Inc. (NASDAQ:ASRT) has declined 48.98% since February 7, 2018 and is downtrending. It has underperformed by 48.98% the S&P500.
Assertio Therapeutics, Inc., a specialty pharmaceutical company, engages in the development, sale, and licensing of products for pain and other central nervous system conditions in the United States. The company has market cap of $273.52 million. It offers Gralise , an once-daily product for the management of postherpetic neuralgia; CAMBIA (diclofenac potassium for oral solution), a non-steroidal anti-inflammatory drug indicated for acute treatment of migraine attacks in adults; and Zipsor (diclofenac potassium) liquid filled capsule, a non-steroidal anti-inflammatory drug for the treatment of mild to moderate acute pain in adults. It has a 9.72 P/E ratio. The firm also provides NUCYNTA ER (tapentadol extended release tablet), a product for the management of pain severe enough to long term opioid treatment, including neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults; and NUCYNTA IR (tapentadol), a product for the management of moderate to severe acute pain in adults.
More notable recent Assertio Therapeutics, Inc. (NASDAQ:ASRT) news were published by: Globenewswire.com which released: “Assertio Therapeutics Announces Amendment of its Senior Secured Credit Facility – GlobeNewswire” on January 09, 2019, also Nasdaq.com with their article: “ASRT vs. COLL: Which Stock Should Value Investors Buy Now? – Nasdaq” published on January 30, 2019, Nasdaq.com published: “Top Ranked Growth Stocks to Buy for January 22nd – Nasdaq” on January 22, 2019. More interesting news about Assertio Therapeutics, Inc. (NASDAQ:ASRT) were released by: Nasdaq.com and their article: “Top Ranked Growth Stocks to Buy for January 18th – Nasdaq” published on January 18, 2019 as well as Globenewswire.com ‘s news article titled: “Assertio Therapeutics Announces Third-Quarter 2018 Financial Results – GlobeNewswire” with publication date: November 08, 2018.
Cooper Tire & Rubber Company, together with its subsidiaries, designs, makes, and markets replacement tires in North America, Latin America, Europe, and Asia. The company has market cap of $1.69 billion. The firm operates through Americas Tire Operations and International Tire Operations divisions. It has a 48.99 P/E ratio. It makes and markets passenger car, light truck, motorcycle, and racing tires, as well as tire retread material; and distributes tires for racing, medium trucks, and motorcycles.
Rutabaga Capital Management Llc Ma holds 3.47% of its portfolio in Cooper Tire & Rubber Company for 533,943 shares. Fairpointe Capital Llc owns 3.64 million shares or 2.64% of their US portfolio. Moreover, Deprince Race & Zollo Inc has 1.91% invested in the company for 3.01 million shares. The New York-based Euclidean Technologies Management Llc has invested 1.89% in the stock. Salem Capital Management Inc, a Massachusetts-based fund reported 85,450 shares. Cooper Tire & Rubber Company (NYSE:CTB) Institutional Positions Chart
Click here to view original web page at $-0.30 EPS Expected for Assertio Therapeutics, Inc. (ASRT); Cooper Tire & Rubber Co Has 1.12 Sentiment